Introduction
Numerous cytogenetic studies have demonstrated that most human neoplasms carry chromosomal aberrations. Leukemias, lymphomas and solid tumours have been shown to carry speci®c chromosomal abnormalities. A variety of studies have shown that these chromosome translocations result in the altered expression and/or structure of cellular gene products, leading to functional activation which contributes to the initiation or progression of the neoplastic state (Rabbitts, 1994) .
Rhabdomyosarcoma, a malignant tumour arising from skeletal muscle precursors, is the commonest form of soft-tissue sarcoma in childhood. The majority of alveolar rhabdomyosarcomas are characterized by a speci®c chromosome translocation ± t(2;13)(q35;q14) (Douglass et al., 1987) . This translocation has been shown to cause the fusion of 5' DNA-binding domains of the PAX3 gene to 3' regions of the FKHR gene, resulting in the expression of a chimeric protein product Galili et al., 1993) . The genomic breakpoints appear to occur consistently in the 17.5 kb intron 7 of the PAX3 gene on chromosome 2 and a large 130 kb intron 1 of the FKHR gene on chromosome 13 (Davis et al., 1995) .
Two consequences of the t(2;13) translocation have been described. Firstly, although the DNA binding of PAX3/FKHR protein is impaired relative to that of PAX3 protein, the fusion protein is a much more potent transcriptional activator and will transform under conditions in which wild-type PAX3 is not (Fredericks et al., 1995; Scheidler et al., 1996) . Secondly, both PAX3 and the PAX3/FKHR fusion protein inhibit the myogenic dierentiation of myoblasts, with the latter demonstrating enhanced inhibitory ability. This ability is dependent on both the paired box and the homeodomain being intact (Epstein et al., 1995) .
Chromosome translocations in malignant tumours may arise by a variety of mechanisms. The translocations seen in some lymphomas and leukemias involve the immunoglobulin or T cell receptor genes (Rabbitts, 1994) . The presence of the Ig/TCR recombinase signal sequence on both aected chromosomes indicates that errors in normal gene rearrangement are responsible for translocations in these cases. The breakpoint junctions of chromosome translocations in some other lymphoid malignancies are characterized by another consensus sequence. A protein, puri®ed from the Lymphoid cell line DND-41, binds to oligonucleotides based on sequences from a number of dierent breakpoint junctions of this kind (Aoki et al., 1995) . The gene, named Translin, which codes for this protein has been identi®ed and cloned, and is characterized by a leucine zipper DNA-binding motif, eight potential phosphorylation sites and one N-glycosylation site. Translin protein is located in the nucleus and cytoplasm in lymphoid cell lines, but in the cytoplasm only of non-lymphoid and non-haematopoetic cell lines (Aoki et al., 1995) .
Similar motifs have not yet been reported at translocation breakpoints in solid tumours, and the mechanisms by which translocations in these tumours occur remain obscure. We wished to know if there were sequence motifs¯anking the breakpoints in the t(2;13) translocation which might predispose to rearrangements occurring in these particular regions.
Results

Cloning of the derivative chromosome 13 translocation breakpoint in Rh28
Vectorette PCR (Riley et al., 1990 ) was used to clone novel unknown chromosome 13 sequences that have been juxtaposed to known, chromosome 2, PAX3 intronic sequences as a result of the t(2;13) chromosome translocation in rhabdomyosarcoma cell lines Rh28, Rh5 and TTC487. Genomic DNA was digested with an appropriate restriction enzyme, and the resulting fragments then ligated to compatible vectorette`adapters' to produce a vectorette`library'. DNA fragments spanning the translocation breakpoint were then identi®ed by using an appropriately sited PAX3 intron primer together with a vectorette adapter primer in PCR. To con®rm that any novel sequence cloned in this way is derived from chromosome 13, primers based on this sequence could be used to amplify a PCR product from a somatic cell hybrid which contains human chromosome 13 as its only human component (PGME1 or 289) (Cowell and Mitchell, 1989; Zhong et al., 1992) .
The genomic translocation breakpoint of the Rh28 cell line has been mapped previously to a 0.6 kb region between a SacI and a ApaI site in the 17.5 kb intron 7 of the PAX3 gene (see Figure 1b) . The presence of these two restriction sites was con®rmed in the sequence of the intron in the Genbank database (accession no. U12259) . To verify that intron sequences 5' of the SacI site were still present in the derivative 13 chromosome, genomic DNA from Rh28 and the associated derivative chromosome 13 bearing RHF14 somatic cell hybrid (see Materials and methods) were used as template to amplify a 484 base-pair fragment from positions 12794 to 13278 in the intron. This product includes a PstI site at position 12845 (see Figure 1c) . The expected products were ampli®ed and subsequent digestion of these products with PstI restriction enzyme resulted in two fragments of the predicted size, 51 and 433 basepairs.
Four vectorette libraries were constructed in total from genomic DNA from Rh28 or RHF14 cell lines, one pair using HaeIII restriction enzyme and another pair using Sau3A restriction enzyme. Nested primers were designed based on sequences immediately 5' of the SacI site and were used in conjunction with vectorette adapter primers. Primers 12800F and UVP were used in a ®rst round of ampli®cation, and nested primers 13300F and USP were used in a second round of ampli®cation. A 200 bp product was ampli®ed from the Rh28/HaeIII and the RHF14/HaeIII vectorette libraries. A 400 bp product was ampli®ed from the Rh28/Sau3A and the RHF14/Sau3A vectorette libraries (see Figure 1c) . All four products were cloned and sequenced. All four sequencing experiments indicate that the genomic breakpoint occurred at positon 13402/3 of the PAX3 intron. Novel sequence, presumed to represent FKHR intron on chromosome 13, was present 3' of the breakpoint in both Sau3A and HaeIII library clones. Two hundred and sixty nine base-pairs of novel sequence were identi®ed in the Sau3A clones, of which the ®rst 66 base-pairs exactly matched those present in the HaeIII clones (see Figure  2a) .
Cloning of chromosome 13 sequences which span the translocation breakpoint in Rh28
The novel sequences found 3' of the derivative 13 translocation breakpoint were used to design a second pair of nested primers. Primers 50R and UVP were used in a ®rst round of ampli®cation using the same vectorette libraries as above. Nested primers 30R and USP were used in second round ampliciation. A 150 bp and a 800 bp product was ampli®ed from the Rh28/ HaeIII vectorette library and a similar 800 bp product was ampli®ed from the RHF14/HaeIII vectorette library (see Figure 1d ). The 800 bp products were of the size predicted if ampli®cation was from the derivative 13 chromosome template. The 150 bp product, present in Rh28 only, ought to represent normal chromosome 13 sequence. No product could be identi®ed from the Rh28/Sau3A or the RHF14/Sau3A vectorette libraries. The 150 bp ampli®cation product was then cloned and sequenced. The sequence immediately adjacent to the 30R primer matches that of the clones from the derivative chromosome 13 up to the breakpoint. The clone also contained 111 bp of unique sequence 5' of the breakpoint. Together with the sequences 3' of the breakpoint on the derivative chromosome 13, a total of 380 bp of novel sequence have been cloned. To con®rm that this novel sequence represents a contiguous region of chromosome 13, a primer pair spannning the breakpoint in this unique sequence were designed. The expected 313 bp product could be ampli®ed from Rh28, Placenta, PGME1 and 289 genomic DNA. Sequence of the products con®rmed the ®delity of the ampli®cation reaction. Figure 2b includes the entire sequence obtained from chromosome 13.
Cloning of the derivative chromosome 2 translocation breakpoint in Rh28
To determine whether there have been any insertions and/or deletions associated with the chromosme translocation we used a similar approach as above to clone the reciprocal translocation breakpoint on derivative chromosome 2. Nested primers, 13600R and 13500R, were designed, based on sequences in the PAX3 intron immediately 3' of position 13402/3, now established as the translocation breakpoint position on the derivative chromosome 13. It is possible that these sequences are deleted from derivative chromosome 2 but there is no straightforward way of testing this hypothesis as a somatic cell hybrid cell line containing derivative chromosome 2 material only is not available.
Ampli®cation of the Rh28/HaeIII and Rh28/Sau3A vectorette libraries was carried out with primers 13600R and UVP, followed by nested 13500R and USP primers. A 300 bp product was ampli®ed from the Rh28/Sau3A vectorette library and a 900 bp product ampli®ed from the Rh28/HaeIII vectorette library (see Figure 1a) . The 900 bp product was of the size predicted for normal chromosome 2. The 300 bp product, presumed to be derived from the derivative chromosome 2, was cloned and sequenced (see Figure  2c) . The ®rst 164 bp of sequence extending from the 13500R primer matched the original chromosome 2 sequence, indicating that the translocation breakpoint in the derivative 2 chromosome is at position 13301/2 of the PAX3 intron. The breakpoint in the derivative 13 chromosome is at position 13402/3. As 101 bp of chromosome 2 sequence is present in both derivative chromosomes, there appears to have been a duplication of this region. The ®nal 82 bp sequence of this clone is again novel and does not match the newlyderived chromosome 13 sequence described above. The 82 bp sequence could be ampli®ed from Rh28 and placental genomic DNA, but not from somatic cell hybrids containing chromosome 2 or 13 as their only human components (GM10826B, 289 and PGME1). Since the 82 bp sequence is not derived from either chromosome 2 or chromosome 13 an insertion of material from some other chromosome may have occurred.
Cloning the derivative 13 breakpoints in two other t(2;13) bearing cell lines Rh5 and TTC487
The breakpoints in the PAX3 gene for the cell lines Rh5 and TTC487 have been mapped and lie in dierent regions of intron 7 to that of Rh28. The Rh5 breakpoint region lies in a 869 bp region between a XbaI site at position 11078 and a EcoRI site at position 11947, approximately 2 kb 5' of the Rh28 breakpoint within intron 7. The TTC487 breakpoint lies between a BglI site at position 4221 and a AvaII site at position 4741. This 520 bp region is 7 kb 5' of the Rh5 breakpoint region and 9 kb 5' of the Rh28 breakpoint. Vectorette libraries were constructed from Rh5 genomic DNA using Sau3A restriction enzyme, and from TTC487 genomic DNA using TaqI restriction enzyme. Nested primers were designed from sequences immediately 5' of each breakpoint region and used in conjunction with vectorette primers in a nested PCR protocol as above. A 300 bp product from the Rh5 reaction and a 400 bp product from the TTC487 reaction were cloned and sequenced.
The sequence of the 300 bp clone from the Rh5 library matches the published PAX3 intron 7 sequence up to position 11099 followed by 316 bp of novel sequence. PCR with primers based on this sequence on somatic cell hybrids, PGME and 289, con®rmed that the 316 bp of novel sequence derives from chromsome 13. The sequence of the 400 bp clone from the TTC487 library matches the published PAX3 intron 7 sequence up to position 4557 followed by 51 bp of novel sequence. The 51 bp of novel sequence in this clone is not large enough to analyse by PCR to con®rm whether it is derived from chromosome 13 or not. Figure 2a includes the entire 423 base pairs sequenced from the derivative chromosome 13 junction fragment in Rh28 and Figure 2c the derivative chromosome 2 junction fragment in Rh28. Figures 2d and 2e include the derivative 13 sequences from cell lines Rh5 and TTC487 respectively. A search of the sequences around the translocation breakpoints did not reveal the presence of dyad symmetries, short direct repeats, interspersed repetitive sequences, oligopurine/oligopyrimidine sites or recombinase signal sequences. We noted possible homology with the recently described consensus recognition sequence for Translin protein adjacent to the derivative chromosome 13 junctions (Table 1) . For example, the sequence in the PAX3 intron from position 13387 to 13399 is ATGAAGGA-CAATA which has a 62% homology to the translin consensus sequence. This sequence is just 3 nucleotides from the derivative 13 breakpoint in Rh28. Three nucleotides on the 3' side of the Rh28 derivative 13 breakpoint is the sequence TTTAAGACCTGCT which again displays 62% homology to the translin consensus sequence. This ®nding implies that Translin could have a role in the genesis of the translocation Table 1 Homology between the translin consensus sequence binding site and sites found¯anking chromosome translocation breakpoints. The consensus sequence was derived by Aoki et al from the chromosome breakpoint junctions in 91 cases of human lymphoid neoplasm including the three sequences indicated below. These three sequences were also shown to bind translin protein in gel shift assays (Aoki et al, 1995) TTGCAGTGA  G  CCG  GTGAAGGCT  C  CGC  CTGCACGTG  C  GAT  ATGAAGGAC  A  ATA  TTTAAGACC  T  GCT  ATGCAACTC  A  TTT  AGGGTAGTC  T  CCT  TTGTTTGCT  T  CCT  ATGCATATA  T  GTA   ±  62  62  43  62  62  62  62  62  43 Aoki Chen et al., 1989 Boehm et al., 1988 Baron et al., 1993 t(2;13)(q35;q14). Thus, we sought to determine if these DNA sequences could bind Translin protein.
Analysis of sequences around the translocation breakpoints
ATGCAGGCC (A/T) CCT
Protein binding studies
Whole cell protein extracts were prepared from RD, an embryonal rhabdomyosarcoma cell line, Rh30, a t(2;13) bearing alveolar rhabdomyosarcoma cell line, and several other cell lines which previously have been shown to contain Translin protein (Aoki et al., 1995) . Gel mobility shift assays have shown that translin protein will bind to oligonucleotides which are based on sequences immediately adjacent to chromosome translocation breakpoints in a range of lymphoid tumours (Aoki et al., 1995) . An oligonucleotide, based on the sequence found 5' of the (2;13) translocation breakpoint in Rh28, was used in gel mobility shift assays. Protein from all the cell lines tested, including the rhabdomyosarcoma lines, bound to oligonucleotide. When unlabelled oligonucleotide was included as speci®c competitor at 40 ± 160-fold molar excess over labelled probe, it was evident that formation of stable labelled complex with protein was considerably reduced (Figure 3a) . When a non-speci®c unlabelled oligonucleotide was included as a competitor, no reduction in complex formation was observed. Speci®city of complex formation was further characterized by preincubation with either preimmune IgM or anti-translin antibody (a gift of Dr M Kasai). The epitope of the translin antibody is at or near the DNAbinding element of translin protein and thus prevents its binding to labelled oligonucleotide in this assay. A small reduction is apparent when 0.1 mg of translin antibody is included in the reaction and a large reduction is apparent when 0.5 mg of antibody is included. There is no reduction in binding when the non-speci®c antibody is included. Binding of protein to oligonucleotide was blocked with the anti-translin antibody but was unaected by preimmune antibody, further supporting the notion that translin binds sequences found next to the t(2;13) breakpoint in Rh28 (Figure 3b ).
Discussion
We report the molecular cloning of the t(2;13) translocation breakpoints that lie in the PAX3 and FKHR genes, occurring on chromosomes 2 and 13 respectively, in the cell lines Rh28, Rh5 and TTC487. Breakpoints within both genes are intronic. At the molecular level, the rearrangement in Rh28 is complex, and involves both a duplication of 101 bp of PAX3 intron sequence adjacent to the breakpoint and a possible insertion of undetermined size. The functional consequences of this translocation mandate that the breakpoint in PAX3 lies in intron 7 and in FKHR in intron 1, as the resulting chimeric gene on the derivative chromosome 13 requires PAX3 exons 1 ± 7 and FKHR exons 2 and 3 for activity. Is there any evidence that DNA sequence¯anking the breakpoints predisposes to translocations involving these two genes? The presence of putative binding sites for the protein translin was noted. Translin has been previously identi®ed by its ability to bind to conserved sequences adjacent to chromosome translocation breakpoints in a variety of lymphoid malignancies. Homology is seen in both components of the derivative chromosome 13, unlike the situation in lymphoid tumours where the recognition sequence is only normally present on the 5' side of the translocation. Typically, the DNA sequences seen in lymphoid tumours have a 50 ± 70% homology to the consensus recognition sequence. We have shown that Translin protein is present in rhabdiod cell lines and that it will bind to oligonucleotides that are based on the putative translin binding sites found¯anking chromosome translocation breakpoints. These ®ndings raise the possibility that the chromosomal rearrangement seen in alveolar rhabdomyosarcoma arises in part as a result of an interaction of damaged DNA with activity of Translin or a related (Aoki et al., 1995) . The data presented here raise the intriguing possibility that active transport of Translin protein is associated with a nuclear mechanism which may result in the formation of a chromosome translocation.
It is the ®rst time such an observation has been made in a solid tumour. Clearly, it is now essential to analyse further examples of alveolar RMS and other non-lymphoid tumour speci®c translocation breakpoints to see if the junction fragments in these tumours also display Translin sequence homology.
Materials and methods
Cell lines and monochromosomal somatic cell hybrids
Rh28, Rh5 and TTC487 are alveolar rhabdomyosarcoma cell lines which contain the translocation t(2;13)(q35;q14) (Douglas et al., 1987; Galili et al., 1993; Sorensen et al., 1995) . RHF14 is a somatic cell hybrid which contains the derivative 13 chromosome from Rh28 but not the derivative chromosome 2 or normal chromosome 2 (Mitchell et al., 1991) . PGME1 and 289 are somatic cell hybrids with human chromosome 13 as their only human component (Cowell and Mitchell, 1989; Zhong et al., 1992) . GM10826B is a somatic cell hybrid with human chromosome 2 as its only human component. 289 and GM10826B genomic DNA were supplied by the UK HGMP Resource Centre. Rh28, RHF14 and PGME1 genomic DNA was extracted and puri®ed using a Nucleon genomic DNA extration kit (Scotlab).
Construction of vectorette libraries
Five mg of each DNA was digested in buer containing 5 units of restriction enzyme (Boehringer Mannehim) in a ®nal volume of 50 ml. Digests were then heat denatured at 708C for 10 min. One ml of each digest was ligated together with 3 pmol of appropriate vectorette adaptor (Genosys) in the presence of 1 mM ATP and 10 units of T4 DNA ligase (Amersham). After 4 h at room temperature, 60 ml of water was added. Vectorette libraries were stored in aliquots at 7208C (Riley et al., 1990) .
Primer design
Primers that are speci®c to chromosome 2 have been based on the intron 7 sequence of the PAX3 gene deposited in Genbank (accession number U12259) . The universal vectorette primer (UVP) and the universal sequencing primer (USP) were both supplied by Genosys. Other primers were synthesized by phosphoramidite chemistry on an Applied Biosystems 380B instrument: 12800F 5'-GCTGTGCTGAGTGCTGTGG-3'; 13300F 5'-TAGCTCATGGGAAAGTGTGC-3'; 50R 5'-GGTTGC-GGAGGGTTATTGTCG-3'; 30R 5'-AAATGTTGGGG-ATCTCGTCC-3'; 13600R 5'-CATGAATAAGTTGTGT-TAAGC-3'; 13500R 5'-CTATATCAGTCCAGAGAGG-3'; Rh5F 5'-GTTAAATTAGAAGAACATCTGCC-3'; Rh5FN 5'-GGTTATGCAACTCATTTCTGC-3'; TTC F 5'-GCTG-TTCAAACTCTCTGAAG-3'; TTC FN 5'-GCAATTATA-GATTGCAACC-3'
Ampli®cation of vectorette libraries
A 5 ml aliquot of each vectorette library was ampli®ed in a total volume of 50 ml containing 10 mM Tris-CL pH 8.3, 50 mM KCL, 1.5 mM MgCl 2 , 0.1% gelatin, 100 mM dNTP and 1 pmole of each primer. Reaction mixtures were denatured at 948C for 5 min before adding 1 unit of Taq DNA polymerase (Perkin-Elmer Cetus) and 1 unit of Perfectmatch enhancer (Stratagene). Subsequent cycles consisted of 1 min at 948C, 1 min at 588C and 2 min at 728C for a total of 40 cycles. One ml of a 1 : 100 dilution of each reaction mixture was used in a further round of ampli®cation under the same reaction conditions (but excluding Perfectmatch enhancer) using nested primers. Aliquots of the reactions were analysed on 1.5% agarose gels.
Ampli®cation products were cloned directly into pCRII plasmid vector (Invitrogen). Plasmid DNA from clones was isolated using Wizard Miniprep (Promega), and then alkali denatured prior to sequencing. For each sequencing reaction 2 mg of double stranded plasmid DNA and 6 ng of primer were used in the Sequenase system ver 2.0 (USB/Amersham). In all sequencing experiments four independent clones were sequenced with vector primers from both strands.
Gel mobility shift assays
Whole cell extracts were prepared from between 5610 5 and 10 7 cells which were washed in ice cold PBS and either scrapped or pelleted into eppendorf tubes and resuspended in 400 ml of ice cold hypotonic buer (10 mM HEPES-KOH pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF) and incubated on ice for 10 min. Cells were then resuspended in 100 ml ice cold hypertonic buer (20 mM HEPES-KOH pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF) and incubated for a further 20 min. Cellular debris was removed by centrifugation for 2 min at 48C, the supernatant was aliquoted and stored at 7708C. Protein concentration was determined by the Lowry method (Sigma).
Oligonucleotides were end-labelled with T4-polynucleotide kinase and [g-32 ]ATP (both Amersham). Seven mg of whole cell extracts were incubated at room temperature for 20 min with 10 000 c.p.m. of 32 P-labelled oligonucleotides (10 pg), in 20 ml of binding buer containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol and 4 mg of poly(dI-dC)(dI-dC). DNA-protein complexes were separated on 5% non-denaturing polyacrylamide gels. Gels were ®xed, dried and autoradiographed.
